No title
Objectives This study evaluates the cost-effectiveness of rechargeable (RC) and nonrechargeable, primary cell (PC) traditional and multimodal spinal cord stimulation (SCS) systems in combination with conventional medical management (CMM) compared with CMM alone in patients with persistent spinal pain syndrome type 2 (PSPS-2) with low back/leg pain that remains despite surgery. Material and Methods
